In Lombardia the adoption of zoledronic could be cost effective when compared to other bisfosfonate in the treatment of postmenopausal osteoporosis

Autor: Ulivieri, Fm, Baio, G, DI TANNA, GIAN LUCA, Integlia, D, Pammolli, F.
Jazyk: angličtina
Rok vydání: 2008
Databáze: OpenAIRE